Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex.
about
Pregabalin add-on for drug-resistant partial epilepsyPregabalin add-on for drug-resistant partial epilepsyPregabalin add-on for drug-resistant partial epilepsyNew molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channelsThe treatment of generalized anxiety disorder with pregabalin, an atypical anxiolyticMolecular targets for antiepileptic drug developmentRoad map for pain management in pancreatic cancer: A reviewPregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive ReviewAntiallodynic effect of pregabalin in rat models of sympathetically maintained and sympathetic independent neuropathic painLavender oil-potent anxiolytic properties via modulating voltage dependent calcium channelsLacosamide: a new approach to target voltage-gated sodium currents in epileptic disordersEmerging evidence for specific neuronal functions of auxiliary calcium channel α₂δ subunits.Acupuncture for the treatment of severe acute pain in herpes zoster: results of a nested, open-label, randomized trial in the VZV Pain Study.Effects of pregabalin in patients with hypnotic-dependent insomnia.Resolution of pregabalin and mirtazapine associated restless legs syndrome by bupropion in a patient with major depressive disorderPregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial.Gabapentin enacarbil - clinical efficacy in restless legs syndromePregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice.Pharmacologic therapies for complex regional pain syndrome.The antiallodynic action of pregabalin may depend on the suppression of spinal neuronal hyperexcitability in rats with spared nerve injuryPharmacokinetics of pregabalin in subjects with various degrees of renal function.Pregabalin: a new anxiolytic.Pregabalin in acute and chronic pain.A comparative study of pre-operative oral clonidine and pregabalin on post-operative analgesia after spinal anesthesia.Pregabalin for the management of fibromyalgia syndromePostdural puncture headache and pregabalin.Quantitative sensory testing predicts pregabalin efficacy in painful chronic pancreatitis.Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.Novel anticonvulsant medications in development.Pregabalin influences insula and amygdala activation during anticipation of emotional images.Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injuryPregabalin in childhood epilepsy: a clinical trial study.A comparison of Ca2+ channel blocking mode between gabapentin and verapamil: implication for protection against hypoxic injury in rat cerebrocortical slices.New Horizons in the development of antiepileptic drugs: Innovative strategies.Amperometric measurement of glutamate release modulation by gabapentin and pregabalin in rat neocortical slices: role of voltage-sensitive Ca2+ α2δ-1 subunitPopulation pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathy.Antiepileptic drugs in neuroprotection.Pregabalin effects on neural response to emotional faces.The therapeutic potential of Na+ and Ca2+ channel blockers in pain management.
P2860
Q24197972-E859FCD3-DBFF-4CC3-B42F-486D683A6AF5Q24242802-DC70D77E-74BB-4E4D-8E65-C7DB656DBB38Q24245146-4460349B-9ED8-4AF8-8B5F-21ABCFA452EAQ24654230-E6F9D1C6-21DE-423F-B255-58169BCE88B5Q24658278-587FA1EB-1832-43EE-9768-8C4BFD2B3398Q24683346-B855E7AF-FE3C-40D1-9D0B-67D7FF55F239Q26738297-50E62EE4-F601-496C-B8C5-54790102DAFFQ28074617-D74EA75D-655E-435E-BE9E-CA34DABC9CD3Q28468636-7AD043F7-50C8-4ABF-83FE-14528BCFCB44Q28487195-E90174C4-D31F-4857-BAF7-78AA8701D1F2Q28833549-C2C6EC4E-0FFF-46FB-A835-9C410601ED4FQ30407837-67F9697D-5BC2-46CA-94FC-8B4EEA510C4DQ31016201-4DD860AC-20F4-444B-ACED-819D010B0825Q33579581-FDAF9346-ADD8-4095-B3EA-B35B705BBCD1Q33600358-B5224591-01F6-4EE2-92E8-E8A914695A86Q33628834-70A65D98-CFF4-448B-9F71-AB935402B800Q33868110-041F22DF-F7D6-4748-AB97-215F73E39450Q33949565-9AE02F3A-72DA-425C-9218-854C9C95098BQ33953965-8913563F-72DF-4D94-81F8-A95136FBDADFQ34038997-C994D681-5054-40E4-AAF2-70C878BA0E24Q34154402-C3F0C86B-F9ED-4F37-9CFC-70BCF1EB1ADEQ34183762-12944462-FBE3-4E57-9F88-3CA406E1D12FQ34187006-8BE12DA2-5FC4-44A2-B887-6A8F20EAB779Q34214071-3D0A6F9E-DBB5-4B4F-AA07-D2E78B0E1886Q34237071-C03AF9B1-63ED-4B91-B072-3E6D5C7FCD0AQ34418349-94478148-0B46-41FB-8E45-242189472630Q34418387-F2B80E98-DAB5-465F-A9C8-E47D89A5B9EBQ34613361-E463A111-9D20-4754-9B3A-2F08E1E694B0Q34645876-27A1189B-E90C-46AB-8EE7-B8FCA1E99841Q34974862-173429A0-7A71-4B2C-9B6E-E3EE96D00B8FQ34988442-334DEE86-C1A9-4E11-A3C0-0A199DFED30BQ35006462-7189B384-E740-44B7-8478-2D868232DB49Q35016781-F499D859-02E2-4DC9-A7B0-B3FD0B6D1EE5Q35045305-99795456-5C77-425F-B233-3E47E7FEC3EAQ35046545-05C41402-32FE-466A-89E8-EECDD8A84C89Q35077880-AE2E9F64-E4BF-41D1-8EA5-12F0BB55771CQ35120597-7D7D60D7-050F-4843-BD7A-EE42E4F5F7D9Q35753392-CD439C5A-C83F-452D-9729-7FA99ED796C6Q35855502-381B6A77-8901-4088-B523-4FA4FD2AB7EAQ35906952-04A10EDE-71B2-4A48-A13B-320D792AAA7E
P2860
Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex.
@en
type
label
Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex.
@en
prefLabel
Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex.
@en
P2093
P1433
P1476
Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex.
@en
P2093
David J Dooley
Hans Clusmann
Klaus Fink
Manfred Göthert
Nirmala Suman-Chauhan
Wolfgang P Meder
P304
P356
10.1016/S0028-3908(01)00172-1
P50
P577
2002-02-01T00:00:00Z